Phase I single-ascending dose study of VT 1161 in healthy volunteers
Latest Information Update: 10 Sep 2013
At a glance
- Drugs Oteseconazole (Primary)
- Indications Vulvovaginal candidiasis
- Focus Adverse reactions; Pharmacokinetics
- 10 Sep 2013 New trial record
- 05 Sep 2013 Status changed from recruiting to completed. VT 1161 recently completed phase I clinical testing, according to a Viamet Pharmaceuticals media release.